Compare Itama Ranoraya Tbk (IRRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Itama Ranoraya Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Itama Ranoraya Tbk trades at Rp374 (market cap 598.4B, 375.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (635.5K versus 375.6K). Which is the better fit depends on your goals.
| IRRA | LABS | |
|---|---|---|
Market Cap | 598.4B | 691.25B |
Volume | 375.6K | 635.5K |
Lot | 3.76K | 6.36K |
Turnover | 139.49M | 110.15M |
Average Price | 371.39 | 173.33 |
Value | 139.49M | 110.15M |
Indicative Equilibrium Price | 374 | 174 |
Indicative Equilibrium Volume | 480 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Itama Ranoraya Tbk
PT. Itama Ranoraya Tbk ( theEntity) was established for the first time based on Deed of Establishment of Limited Liability Entity dated November 30, 1989 Number 116, made before Esther Daniar Iskandar, S.H., Notary in Jakarta. PT Global Dinamika Kencana is the majority shareholder of the Entity and also the Ultimate Parent Entity. The entity has started commercial operations at July 22, 2002.
Read more on IRRA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
